The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and The distribution date will be 11:59 p.m. Burlington, North...
INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits by 33% compared to ...
Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 ...
the Company’s ongoing focus on finalizing its financial statements and other disclosures in its Quarterly Report on Form 10-Q for the fiscal quarter ...
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“BELLUS” or the “Company”) today announced that the Superior Court of Québec ...
Marcus Kuhnert will step down as Chief Financial Officer and Member of the Executive Board after a successful nine-year tenure Helene von Roeder appoint...
Record revenue of $60.2M in 2QFY23; up 25% over $48.1M in 2QFY22 – – Orders increased to $64.2M in 2QFY23; up 17% over 2QFY22 – –...
Recent Highlights Revenue was $134.3 million for the first quarter, representing a 17% increase over the corresponding period of 2022. Surpassed 5,000 ...
Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...
Merck, a leading science and technology company, held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, ...
Tempest will host a conference call accompanied by a slide presentation at 8:30 a.m. ET on Friday, April 28th. To join the conference call via phone and pa...
The items on the agenda of the ordinary and extraordinary general shareholders' meetings include the proposed approval of a number of resolutions relating ...
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposa...
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its res...
© 2024 Biopharma Boardroom. All Rights Reserved.
